Certegra® P3T® 2.0 Software

Certegra P3T Banner

Certegra® P3T® 2.0 Software

Personalized Protocols with Standardized Success

Certegra® P3T® 2.0 software allows technologists to individually optimize contrast protocols at the point of care with ease.

Standardizing and easing implementation of personalized patient protocols offers important benefits, including:

  • Facilitating implementation of multiple CT abdomen protocol strategies
  • Reducing occurrences of suboptimal CT pulmonary angiograph studies1,2
  • Managing cardiac-imaging complexity

The intuitive touchscreen interface of the Certegra® Workstation guides technologists in accounting for unique patient and study variables, in order to personalize protocols for CT cardiac, pulmonary, and abdomen (liver, pancreas, and kidneys) studies. Certegra® P3T® 2.0 extends established P3T protocol personalization capabilities to allow for improved protocol adherence.

Specifically, Certegra® P3T® 2.0 enables technologists to:

  • Preset radiologist-preferred dosing strategies, contrast concentrations, and scan timing
  • Recall up to 250 stored protocols
View the Studies

When compared to standard protocol, P3T PA protocols result in a higher percentage of exams ranked diagnostic without limitation.*1,2

*Albeit at a slightly higher contrast dose than the standard protocol of 80 mL. Images courtesy of the University of Pittsburgh Medical Center (UPMC). Used by permission.


Comparison of cardiac images and enhancement of coronary tree using P3T protocol versus standard injection protocol.

Control Group 1 received 80 mL of CM at 6 mL/s.

P3T Group injection parameters were individually adjusted to patient weight, the duration of CT data acquisition, and attenuation parameters following a test bolus.

Control Group 2 the volume of CM was adjusted to the duration of CT data acquisition and injected at 5 mL/s.

Images provided through the courtesy of the University of Muenster. Used by permission.


The P3T® Abdomen application automatically adjusts contrast volume based on systematic scientific methods, according to patient, procedure, and prescribed physician parameters.

Images provided during evaluation through the courtesy of Rhode Island Hospital. Used by permission.

References: 1. Presented at Society of Thoracic Radiology (2008) Poster Session; Christopher R. Deible MD, PhD. 2. 510(k) FDA clearance number: K082905.

Close Menu